Related Experiment Video
Updated: Dec 5, 2025

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
Published on: September 11, 2021
Responsiveness, minimal important difference, minimal relevant difference, and optimal number of patients for a study
Jonathan David Comins1,2, John Brodersen2,3, Karl Bang Christensen4
1Section for Sports Traumatology M51, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Understanding patient-reported outcome measures (PROMs) is crucial for treatment decisions. This study clarifies terms like minimal important difference (MID) and minimal relevant difference (MIREDIF) for better interpretation of treatment effects and study design.
Area of Science:
- Orthopedics
- Clinical Research Methodology
- Health Outcomes Research
Background:
- Patient-reported outcome measures (PROMs) are vital for assessing treatment efficacy.
- Interpreting changes in PROM scores, such as minimal important difference (MID), is complex and varies.
- These scores influence treatment recommendations and sample size calculations in studies.
Purpose of the Study:
- To provide a theoretical explanation of key terms: responsiveness, minimal important difference (MID), minimal important change (MIC), minimal relevant difference (MIREDIF), and threshold of clinical importance.
- To offer guidance on calculating these measures and determining optimal study sample sizes.
- To illustrate calculations using real-world data from anterior cruciate ligament reconstruction patients.
Main Methods:
- Theoretical explanation of PROM interpretation concepts.
- Illustrative calculations using Knee Injury and Osteoarthritis Outcome Score (KOOS) data from 164 patients.
- Presentation of common methods for calculating and interpreting MID.
Main Results:
- Results for MID calculations vary significantly based on PROM domains, patient scale position, and health conditions.
- Optimal sample size determination is influenced by MIREDIF, standard error of the measure (SEM), statistical power, and PROM responsiveness.
- Uncertainty exists in calculating and interpreting responsiveness, MID, and MIREDIF due to their complexity.
Conclusions:
- Authors must specify MID calculation methods and relevance to the study population when reporting research.
- Clearer understanding and application of MID, MIREDIF, and responsiveness are needed for robust healthcare decisions.
- These measures require careful consideration to justify clinical and research decisions.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Spare Receptors
Dose Size and Dosing Frequency: Determination Methods
Dosage Regimen: Individualization

